Delphi
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Contract Value
Not provided
Codes & Classification
Solicitation Number
ARPA-H-SOL-26-153
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN13
Additional Details
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a solicitation for the Delphi Program (Procurement Identifier: ARPA-H-SOL-26-153). This initiative seeks to revolutionize personal health monitoring by developing modular, wearable, or ingestible biosensors capable of continuously tracking deep biological information such as hormones, cytokines, and drug levels. The overarching goal is to empower individuals with real-time insights into their physiological states, thereby enabling early disease detection, safe home recovery, and precision monitoring of therapeutic interventions.
The Delphi Program is distinguished by its focus on leveraging chiplet-based microelectronic architectures. Unlike traditional Application Specific Integrated Circuits (ASICs), chiplets allow for the modular reuse and integration of high-performance components, facilitating lower costs, reduced size, weight, and power consumption (SWaP), and greater adaptability. This approach is particularly advantageous for biosensing applications, which often require heterogeneous integration due to the diverse materials involved.
Key technical objectives include:
- Development of dry, hermetically sealed chiplets with ultra-low power management capabilities, addressing the limitations of current power-intensive standards and enabling efficient operation through RF or internal power harvesting.
- Creation of secure communication modules to ensure the safe transmission of sensitive medical data from body-worn devices.
- Advancement of “wet” biosensor chiplets that can interface directly with biological systems, extending continuous measurement capabilities from biophysical parameters and high-concentration metabolites to low-concentration biochemical markers such as hormones and cytokines.
- Integration of these chiplets into biocompatible, modular packages that are fully encapsulated except at the sensing interface, overcoming the shortcomings of existing encapsulation methods in terms of selectivity, reliability, and scalability.
The intended outcomes of the Delphi Program are to catalyze the biosensor development ecosystem, making high-performance, low-cost sensing technologies widely accessible and adaptable for a range of health monitoring applications. The program aims to deliver robust, scalable solutions that support durable, long-term operation in biological environments, ultimately improving health outcomes through enhanced monitoring and early intervention.
This solicitation is classified under NAICS Code 541715 (Research and Development in the Physical, Engineering, and Life Sciences, except Nanotechnology and Biotechnology) and Product Service Code AN13. The place of performance is within the United States.
The procurement is currently active, with the solution summary due by Wednesday, April 8, 2026, at 5:00 PM ET—a prerequisite for proposal submission. The final response date is May 13, 2026, at 9:05 PM ET. Contractors should note that Amendment 1, issued on April 30, 2026, updated several appendices related to proposal formatting, technical and management requirements, the price proposal spreadsheet, and model OT formatting; no other changes to the solicitation have been made.
Interested parties are encouraged to review the full solicitation and associated attachments, available via the SAM.gov opportunity listing (Opportunity ID: b0a37b55ad27489ca8c20136d5b48c18), and direct any inquiries to the primary contact at [email protected].
This opportunity is particularly suited for organizations with expertise in microelectronics, biosensor development, biocompatible packaging, and secure medical data communications, seeking to contribute to transformative advancements in personal health monitoring technologies.
Documents14